A phase one trial of carfilzomib, bendamustine, and dexamethasone in relapsed and/or refractory multiple myeloma.

ABSTRACT:

SUBMITTER: Lee HC 

PROVIDER: S-EPMC8252413 | biostudies-literature | 2021 Jul

REPOSITORIES: biostudies-literature